药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Insulin glulisine
Perflubutane
Perflubutane can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Ferric oxide
Ferric oxide can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Gleptoferron
Gleptoferron can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Ferrous bisglycinate
Ferrous bisglycinate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Ferric sulfate
Ferric sulfate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Ferumoxides
Ferumoxides can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Ferumoxsil
Ferumoxsil can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Ferric ammonium citrate
Ferric ammonium citrate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Ferric pyrophosphate
Ferric pyrophosphate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Iron sucrose
Iron sucrose can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Prussian blue
Prussian blue can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Iron
Iron can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Insulin glulisine
Montmorillonite
The serum concentration of Dolutegravir can be decreased when it is combined with Montmorillonite.
Insulin glulisine
Aloglutamol
The serum concentration of Dolutegravir can be decreased when it is combined with Aloglutamol.
Insulin glulisine
Hydrotalcite
The serum concentration of Dolutegravir can be decreased when it is combined with Hydrotalcite.
Insulin glulisine
Bentonite
The serum concentration of Dolutegravir can be decreased when it is combined with Bentonite.
Insulin glulisine
Aluminum sulfate
The serum concentration of Dolutegravir can be decreased when it is combined with Aluminum sulfate.
Insulin glulisine
Aluminum chloride
The serum concentration of Dolutegravir can be decreased when it is combined with Aluminum chloride.
Insulin glulisine
Potassium alum
The serum concentration of Dolutegravir can be decreased when it is combined with Potassium alum.
Insulin glulisine
Magaldrate
The serum concentration of Dolutegravir can be decreased when it is combined with Magaldrate.